Bernard M. Nordlinger

Bernard M. Nordlinger's AcademicInfluence.com Rankings

Philosophy

#8303

World Rank

#11656

Historical Rank

Logic

#5339

World Rank

#6730

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Bernard M. Nordlinger's Degrees

Doctorate Medicine Harvard University

Why Is Bernard M. Nordlinger Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Bernard M. Nordlinger's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial (2008) (1716)
Surgical resection of colorectal carcinoma metastases to the liver: A prognostic scoring system to improve case selection, based on 1568 patients (1996) (1673)
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. (2012) (1300)
Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial. (2010) (1067)
Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2014) (971)
Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. (2013) (897)
Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2013) (789)
Preoperative Radiotherapy as Adjuvant Treatment in Rectal Cancer: Final Results of a Randomized Study of the European Organization for Research and Treatment of Cancer (EORTC) (1988) (675)
Influence of Preoperative Chemotherapy on the Risk of Major Hepatectomy for Colorectal Liver Metastases (2006) (675)
Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954. (2010) (581)
Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of (2000) (539)
Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. (2006) (531)
Complete response of colorectal liver metastases after chemotherapy: does it mean cure? (2006) (500)
Towards a pan-European consensus on the treatment of patients with colorectal liver metastases. (2006) (497)
Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer. (1995) (466)
Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment. (2010) (442)
Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3. (2009) (438)
Colorectal cancer (2010) (437)
Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel. (2009) (374)
Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004). (2011) (361)
Long‐term survival following resection of colorectal hepatic metastases (1997) (345)
Vascular Occlusions for Liver Resections: Operative Management and Tolerance to Hepatic Ischemia 142 Cases (1989) (343)
Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up. (2010) (342)
Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986. (2005) (329)
Hepatic Resection for Colorectal Liver Metastases: Influence on Survival of Preoperative Factors and Surgery for Recurrences in 80 Patients (1987) (303)
Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial (2017) (277)
Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group. (2007) (270)
OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer. (2005) (249)
Integrated analysis of molecular and clinical prognostic factors in stage II/III colon cancer. (2012) (225)
Colorectal metastasis (liver and lung). (2002) (221)
Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 cases. Association Francaise de Chirurgie. (1994) (220)
Normothermic hepatic vascular exclusion for extensive hepatectomy. (1978) (195)
Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases (2005) (192)
Impaired Mobility, ASA Status and Administration of Tramadol are Risk Factors for Postoperative Delirium in Patients Aged 75 Years or More After Major Abdominal Surgery (2010) (191)
Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin‐3 and BM‐40/SPARC genes (1995) (180)
Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983. (2014) (177)
Hemodynamic and biochemical monitoring during major liver resection with use of hepatic vascular exclusion. (1984) (159)
Tritherapy with fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastases (2008) (156)
Perioperative FOLFOX 4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer ( EORTC 40983 ) : long-term results of a randomised , controlled , phase 3 trial (2013) (152)
Urgent need for a new staging system in advanced colorectal cancer. (2008) (151)
Tolerance of the human liver to prolonged normothermic ischemia. A biological study of 20 patients submitted to extensive hepatectomy. (1978) (145)
Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801). (2005) (144)
Dormant liver metastases: an experimental study (1992) (141)
Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note. (2005) (140)
Randomized phase III trial comparing infused irinotecan/5-fluorouracil (5-FU)/folinic acid (IF) versus 5-FU/FA (F) in stage III colon cancer patients (pts). (PETACC 3) (2005) (137)
Deep Learning and Radiomics predict complete response after neo-adjuvant chemoradiation for locally advanced rectal cancer (2018) (136)
Ileal pouch-anal anastomosis as the first choice operation in patients with familial adenomatous polyposis: a ten-year experience. (1996) (135)
Surgical management of hepatic metastases from colorectal malignancies. (2001) (134)
The ratio of metastatic to examined lymph nodes is a powerful independent prognostic factor in rectal cancer (2008) (131)
Identification in Daily Practice of Patients With Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer): Revised Bethesda Guidelines-Based Approach Versus Molecular Screening (2008) (128)
A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial. (2005) (126)
Surgical resection of hepatic metastases. Multicentric retrospective study by the French Association of Surgery (1992) (123)
Long-term survival following resection of colorectal hepatic metastases. Association Française de Chirurgie. (1997) (122)
The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010. (2011) (121)
Risk factors for chemotherapy-associated liver injuries: A multivariate analysis of a group of 146 patients with colorectal metastases. (2009) (117)
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008. (2009) (117)
Where does pelvic nerve injury occur during rectal surgery for cancer? (2011) (113)
The Role of Preoperative Chemotherapy in Patients with Resectable Colorectal Liver Metastases (2009) (112)
Operation and abdominal desmoid tumors in familial adenomatous polyposis. (1993) (108)
Liver resection with normothermic ischaemia exceeding 1 h (1993) (106)
Intrasplenic hepatocellular transplantation corrects hepatic encephalopathy in portacaval‐shunted rats (1992) (105)
Rectopexy to the promontory for the treatment of rectal prolapse (1984) (104)
Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin versus capecitabine alone in locally advanced rectal cancer: Disease-free survival results at interim analysis. (2014) (104)
Repeat liver resection for recurrent colorectal metastases (1993) (103)
Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis. (1998) (102)
Radical surgery and postoperative radiotherapy as combined treatment in rectal cancer. Final results of a phase III study of the European Organization for Research and Treatment of Cancer (1997) (99)
Predictive Factors for the Benefit of Perioperative FOLFOX for Resectable Liver Metastasis in Colorectal Cancer Patients (EORTC Intergroup Trial 40983) (2012) (95)
Survival benefit of repeat liver resection for recurrent colorectal metastases: 143 cases. (1997) (88)
RADIOFREQUENCY ABLATION (RFA) COMBINED WITH CHEMOTHERAPY FOR UNRESECTABLE COLORECTAL LIVER METASTASES (CRC LM): INTERIM RESULTS OF A RANDOMISED PHASE II STUDY OF THE EORTC-NCRI CCSG-ALM INTERGROUP 40004 (CLOCC) (2008) (86)
Adjuvant intraperitoneal 5-fluorouracil in high-risk colon cancer: A multicenter phase III trial. (2000) (83)
Colorectal cancer – Authors' reply (2010) (83)
Overexpression of nm23-H1 and nm23-H2 genes in colorectal carcinomas and loss of nm23-H1 expression in advanced tumour stages. (1995) (81)
Function of ileal J pouch‐anal anastomosis in patients with familial adenomatous polyposis (1993) (81)
Angiography in portal hypertension: clinical significance in surgery. (1980) (80)
Adjuvant therapy of poor prognosis colon cancer with levamisole: Results of an EORTC double‐blind randomized clinical trial (1989) (79)
Benefits and risks of neoadjuvant therapy for liver metastases. (2006) (78)
Excision of the rectum with colonic J pouch-anal anastomosis for adenocarcinoma of the low and mid rectum (1992) (77)
1088 Irinotecan improves the activity of the AIO regimen in metastatic colorectal cancer: results of EORTC GI group study 40986 (2003) (72)
Accuracy of Magnetic Resonance Imaging in Rectal Cancer Depends on Location of the Tumor (2005) (71)
Final results of the EORTC Intergroup randomized phase III study 40983 [EPOC] evaluating the benefit of peri-operative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases (2007) (69)
Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin versus capecitabine alone in locally advanced rectal cancer: First results of the PETACC-6 randomized phase III trial (2013) (66)
Prognostic impact of immune response in resectable colorectal liver metastases treated by surgery alone or surgery with perioperative FOLFOX in the randomised EORTC study 40983. (2015) (66)
Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009. (2010) (64)
An experimental study of survival after two hours of normothermic hepatic ischemia. (1980) (64)
The diagnosis and management of rectal cancer: expert discussion and recommendations derived from the 9th World Congress on Gastrointestinal Cancer, Barcelona, 2007. (2008) (63)
O-018Radiofrequency ablation (RFA) combined with chemotherapy for unresectable colorectal liver metastases (CRC LM): Long-term survival results of a randomised phase II study of the EORTC-NCRI CCSG-ALM Intergroup 40004 (CLOCC) (2015) (62)
The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006. (2007) (62)
Previous subtotal colectomy with ileostomy and sigmoidostomy improves the morbidity and early functional results after ileal pouch-anal anastomosis in ulcerative colitis (1993) (59)
Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third International Conference: Perspectives in Colorectal Cancer, Dublin, 2001). (2002) (57)
A report of forty-four instances of pancreaticoduodenal resection in patients more than seventy years of age. (1993) (57)
Permeability and biocompatibility of a new hydrogel used for encapsulation of hepatocytes. (1995) (56)
Treatment of Hepatic Metastases of Colorectal Cancer (1993) (55)
Surgery of liver metastases from colorectal cancer: new promises. (2002) (54)
Repeat hepatic resection for primary and metastatic carcinoma of the liver. (1990) (54)
Feasibility and risks of pre-operative chemotherapy (CT) with Folfox 4 and surgery for resectable colorectal cancer liver metastases (LM). Interim results of the EORTC Intergroup randomized phase III study 40983 (2005) (54)
[Digestive oncology: surgical practices]. (2009) (52)
Adjuvant regional chemotherapy and systemic chemotherapy versus systemic chemotherapy alone in patients with stage II-III colorectal cancer: a multicentre randomised controlled phase III trial. (2005) (51)
Endotoxemia of cirrhosis: an observation not substantiated. (1980) (51)
The healing of colonic anastomoses after early intraperitoneal chemotherapy: an experimental study in rats. (1988) (50)
Final results of the EORTC intergroup randomized study 40004 (CLOCC) evaluating the benefit of radiofrequency ablation (RFA) combined with chemotherapy for unresectable colorectal liver metastases (CRC LM). (2010) (48)
Internal bioartificial liver with xenogeneic hepatocytes prevents death from acute liver failure: an experimental study. (1998) (47)
Liver metastases from colorectal cancer: the turning point. (2002) (47)
Secondary proctectomy and ileal pouch—anal anastomosis after ileorectal anastomosis for familial adenomatous polyposis (1993) (46)
Quantitative tests of nitrogen metabolism in cirrhosis: relation to other manifestations of liver disease. (1978) (45)
Docetaxel plus gemcitabine or docetaxel plus cisplatin in advanced pancreatic carcinoma: randomized phase II study 40984 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group. (2005) (45)
The timing of chemotherapy and surgery for the treatment of colorectal liver metastases. (2010) (44)
Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement. (2013) (43)
No evidence of somatic FGFR3 mutation in various types of carcinoma (2001) (43)
Cholestasis induces major histocompatibility complex class I expression in hepatocytes. (1992) (42)
Impact of Chemotherapy on the Accuracy of Computed Tomography Scan for the Evaluation of Colorectal Liver Metastases (2009) (41)
Previous transanal full‐thickness excision increases the morbidity of radical resection for rectal cancer (2012) (41)
High-dose folinic acid, 5-fluorouracil bolus and continuous infusion in poor-prognosis patients with advanced measurable gastric cancer. (1991) (41)
Evidence for survival and metabolic activity of encapsulated xenogeneic hepatocytes transplanted without immunosuppression in Gunn rats. (1997) (40)
EORTC liver metastases intergroup randomized phase III study 40983: Long-term survival results. (2012) (38)
[Transplantation of allogeneic hepatocytes without immunosuppression: long term survival]. (1994) (37)
Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine +/- oxaliplatin in locally advanced rectal cancer: Final results of PETACC-6. (2018) (36)
Multicenter validation study of pathologic response and tumor thickness at the tumor‐normal liver interface as independent predictors of disease‐free survival after preoperative chemotherapy and surgery for colorectal liver metastases (2013) (36)
Pre- and Postoperative Capecitabine Without or With Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD. (2020) (35)
Presentation and prognosis of local recurrence after total mesorectal excision (2009) (34)
Portal Pseudoperfusion: An Angiographic Illusion (1979) (33)
Linear quantification of lymphoid infiltration of the tumor margin: a reproducible method, developed with colorectal cancer tissues, for assessing a highly variable prognostic factor (2012) (33)
Respective Roles of Ammonia, Amino Acids, and Medium‐Sized Molecules in the Pathogenesis of Experimentally Induced Acute Hepatic Encephalopathy (1983) (32)
Hepatectomy for resectable colorectal cancer metastases--indicators of prognosis, definition of resectability, techniques and outcomes. (2007) (32)
Loss of heterozygosity on 10q and mutational status of PTEN and BMPR1A in colorectal primary tumours and metastases (2004) (31)
The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005. (2006) (31)
Should the results of the new EPOC trial change practice in the management of patients with resectable metastatic colorectal cancer confined to the liver? (2015) (31)
Tyrosine metabolism in cirrhosis. (1979) (30)
Large scale trial for adjuvant treatment in high risk resected colorectal cancers. Rationale to test the combination of loco-regional and systemic chemotherapy and to compare l-leucovorin + 5-FU to levamisole + 5-FU. (1993) (30)
Baseline standards for paediatric oncology nursing care in low to middle income countries: position statement of the SIOP PODC Nursing Working Group (2014) (29)
Resection of previously unresectable liver metastases from colorectal cancer (LMCRC) after chemotherapy (CT) with CPT-11/L-OHP/LV5FU (Folfirinox): A prospective phase II trial. (2004) (28)
Regional chemotherapy in the treatment of advanced pancreatic cancer--is it relevant? (2000) (28)
High-yield preparation of porcine hepatocytes for long survival after transplantation in the spleen. (1985) (27)
Resection of previously unresectable liver metastases from colorectal cancer (LMCRC) after chemotherapy (CT) with CPT-11/L-OHP/LV5FU (Folfirinox): A prospective phase II trial (2004) (27)
Experimental model of colon cancer: Recurrences after surgery alone or associated with intraperitoneal 5-fluorouracil chemotherapy (1991) (25)
Experimental colorectal liver metastases. Influence of sex, immunological status and liver regeneration. (1990) (25)
Prolonged survival after resection of pancreatoblastoma and synchronous liver metastases in an adult. (2001) (25)
A common hepatic artery passing in front of the portal vein (2006) (25)
Nonsurgical methods for liver metastases including cryotherapy, radiofrequency ablation, and infusional treatment: what's new in 2001? (2002) (25)
Matrix-comparative genomic hybridization from multicenter formalin-fixed paraffin-embedded colorectal cancer tissue blocks (2007) (24)
Resection of liver metastases from colorectal cancer – how can we improve results? (2003) (24)
Accelerated fibrinogen and platelet destruction after peritoneovenous shunting. (1981) (24)
Transplanted cryopreserved encapsulated porcine hepatocytes are as effective as fresh hepatocytes in preventing death from acute liver failure in rats. (2000) (24)
Metabolism of β-muricholic acid in man (1985) (24)
What can we learn from oncology surgical trials? (2016) (23)
Radiofrequency ablation in liver tumours. (2004) (23)
Septic necrosis of the midline wound in postoperative peritonitis. Successful management by debridement, myocutaneous advancement, and primary skin closure. (1988) (23)
A reversible model of acute hepatic failure by temporary hepatic ischemia in the pig. (2000) (22)
[Recommendations for the management of GIST patients]. (2005) (22)
Portal triad clamping (TC) or hepatic vascular exclusion (VE) for major liver resection after prolonged neoadjuvant chemotherapy? A case-matched study in 60 patients. (2006) (22)
Can hepatocytes proliferate when transplanted into the spleen? Demonstration by autohistoradiography in the rat. (1987) (22)
Tumor response to pre-operative chemotherapy (CT) with FOLFOX-4 for resectable colorectal cancer liver metastases (LM). Interim results of EORTC Intergroup randomized phase III study 40983. (2006) (22)
PG 6.2 Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer: disease free survival results at interim analysis (2014) (21)
Evaluation of predictive models in daily practice for the identification of patients with Lynch syndrome (2012) (21)
Neoadjuvant treatment before resection of liver metastases. (2007) (21)
Cutaneous Perianal Recurrence on the Site of Lone Star Retractor™ after J-pouch Coloanal Anastomosis for Rectal Cancer: Report of Two Cases (2008) (20)
THE ISOLATED PERFUSED RAT SPLEEN: AN ORIGINAL METHOD FOR STUDYING THE FUNCTION OF HEPATOCYTES TRANSPLANTED INTO THE SPLEEN (1990) (20)
Survival and functions of encapsulated porcine hepatocytes after allotransplantation or xenotransplantation without immunosuppression. (2001) (20)
Surgery and Local Treatments of Liver Metastases from Colorectal Cancer: How to Improve Results (2003) (19)
Prognostic score for recurrence after Whipple's pancreaticoduodenectomy for ampullary carcinomas; results of an AGEO retrospective multicenter cohort. (2015) (19)
Colorectal cancer: Metastatic colorectal cancer outcome and fatty liver disease (2013) (18)
Administration of exogenous interleukin-2 abrogates spontaneous rat liver allograft acceptance but does not affect long-term established graft survival. (1997) (18)
Encapsulated xenogeneic hepatocytes remain functional after peritoneal implantation despite immunization of the host. (1998) (18)
Response of liver metastases to preoperative radiochemotherapy in patients with locally advanced rectal cancer and resectable synchronous liver metastases. (2013) (18)
Neoadjuvant therapy of colorectal liver metastases: Lessons learned from clinical trials (2010) (18)
Randomized phase II study of weekly 24 h infusion of high dose 5-FU ± folinic acid (HD-FU±FA) versus HD-FU/FA/biweekly cisplatin in advanced gastric cancer. EORTC-trial 40953 (2001) (18)
Pathological response of locally advanced rectal cancer to preoperative chemotherapy without pelvic irradiation (2015) (18)
A good model of experimental acute hepatic failure: 95% hepatectomy; treatment by transplantation of hepatocytes. (1995) (17)
Preservation of an intra-pancreatic hepatic artery during duodenopancreatectomy for melanoma metastasis (2011) (16)
Hepatic vascular exclusion (HVE) for major liver resections. (1987) (16)
Salvage colectomy for endoscopically removed malignant colon polyps: is it possible to determine the optimal number of lymph nodes that need to be harvested? (2010) (16)
Repeat resections for recurrent colorectal liver metastases. (1994) (15)
Glutamine metabolism and neuropathological disorders in experimental hepatic encephalopathy: effect of transplanted hepatocytes. (1996) (15)
Author Correction: Deep Learning and Radiomics predict complete response after neo-adjuvant chemoradiation for locally advanced rectal cancer (2018) (14)
Evaluation of Clinical Efficacy of New Medical Treatments in Advanced Colorectal Cancer. Results of a Workshop Organized by the Eortc Gitccg (1998) (14)
Deranged Tyrosine Metabolism in Cirrhosis (1978) (14)
The management of metastatic pancreatic cancer: expert discussion and recommendations from the 14th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2012 (2013) (14)
Tyramine kinetics and metabolism in cirrhosis. (1979) (13)
The role of biological agents in the resection of colorectal liver metastases. (2012) (13)
[Comparison of functional results of ileorectal and ileo-anal anastomoses in familial adenomatous polyposis. Conversions of ileorectal anastomoses into ileo-anal anastomoses]. (1992) (13)
Surgical resection of liver metastases from colo-rectal cancers. (1987) (13)
Splenic artery ligation in distal splenorenal shunts. (1978) (13)
Improved retroviral suicide gene transfer in colon cancer cell lines after cell synchronization with methotrexate (2011) (12)
Shanghai international consensus on diagnosis and comprehensive treatment of colorectal liver metastases (version 2019). (2020) (12)
Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer: final analyses (2016) (12)
Semiautomatic Macroencapsulation of Fresh or Cryopreserved Porcine Hepatocytes Maintain Their Ability for Treatment of Acute Liver Failure (2001) (12)
Locoregional chemotherapy for adjuvant treatment of colorectal adenocarcinoma. (1996) (12)
Immunosuppressive effects of endotoxins and bile acids in vivo in the rat (1996) (12)
A model of primary culture of colorectal cancer and liver metastasis to predict chemosensitivity. (2011) (11)
Survival and differentiation of porcine hepatocytes encapsulated by semiautomatic device and allotransplanted in large number without immunosuppression. (2001) (11)
[Diverting loop ileostomy, effective prevention of colonic complications in necrotizing acute pancreatitis]. (1992) (11)
[A good model of acute hepatic failure: 95% hepatectomy. Treatment by transplantation of hepatocytes]. (1996) (11)
Neoadjuvant and adjuvant therapy in relation to surgery for colorectal liver metastases (2012) (10)
Complete calcification of colorectal liver metastases on imaging after chemotherapy does not indicate sterilization of disease. (2012) (10)
LETHAL FECALOMA (2007) (10)
Preoperative systemic chemotherapy alters the histopathological growth patterns of colorectal liver metastases (2021) (10)
Sequenced Chemotherapy and Surgery for Potentially Resectable Colorectal Liver Metastases: A Debate Over Goals of Research and an Approach While the Jury Remains Out (2010) (10)
[Results of ileoanal anastomosis with mucosectomy and "J" pouch in hemorrhagic rectocolitis]. (1994) (10)
Chemotherapy as initial treatment of locally advanced unresectable pancreatic cancer: a valid option? (2007) (9)
Semiautomatic macroencapsulation of large numbers of porcine hepatocytes by coextrusion with a solution of AN69 polymer. (2000) (9)
Suppression of humoral immunization against encapsulated xenogeneic hepatocytes and prolongation of their function by 2-week cyclosporine treatment in the rat. (2000) (9)
Management of patients over 80 years of age treated with resection for localised colon cancer: results from a French referral centre. (2014) (9)
[Hepatectomy for tumor under vascular exclusion. Development of the ideas in the last decade. Apropos of experience with 41 cases]. (1983) (9)
O-0017PREOPERATIVE CHEMORADIOTHERAPY AND POSTOPERATIVE CHEMOTHERAPY WITH CAPECITABINE AND OXALIPLATIN VS. CAPECITABINE ALONE IN LOCALLY ADVANCED RECTAL CANCER: DISEASE FREE SURVIVAL AT INTERIM ANALYSIS (2014) (9)
[Surgical resection of hepatic metastases of cancers of the colon and rectum]. (1983) (9)
[Mixed corticomedullary tumor]. (1998) (9)
Relationship Between Plasma and Brain Tryptophan in Pigs During Experimental Hepatic Coma Before and After Hernodialysis with Selective Membranes (1981) (9)
Can We Predict Complete or Major Response after Chemoradiotherapy for Rectal Cancer by Noninvasive Methods? Results of a Prospective Study on 61 Patients (2014) (9)
Radiofrequency ablation for colorectal cancer liver metastases initially greater than 25 mm but downsized by neo-adjuvant chemotherapy is associated with increased rate of local tumor progression. (2018) (8)
Surgical resection of hepatic metastases. Comments on the results of the multicentric retrospective study by the French Association of Surgery (1992) (8)
Surgery for colon and rectal cancer. (2002) (8)
O-0023PREOPERATIVE CHEMORADIOTHERAPY AND POSTOPERATIVE CHEMOTHERAPY WITH CAPECITABINE AND OXALIPLATIN VS. CAPECITABINE ALONE IN LOCALLY ADVANCED RECTAL CANCER: RESPONSE TO THE LOCAL TREATMENT AFTER CHEMORADIATION AND SURGERY AS SECONDARY ENDPOINT (2013) (8)
OC-0250: First results of the PETACC-6 randomized phase III trial in locally advanced rectal cancer (2014) (8)
Is there a standard adjuvant treatment for rectal cancer? (1998) (7)
Complete radiological response of colorectal liver metastases (LM) after chemotherapy: Does it mean cure? (2006) (7)
Anatomical bases of prolonged ilio-inguinal-hypogastric regional anesthesia (2006) (7)
709PD FIVE-YEAR RESULTS OF THE RANDOMIZED PHASE III TRIAL COMPARING S-1 MONOTHERAPY VERSUS SURGERY ALONE FOR STAGE II/III GASTRIC CANCER PATIENTS AFTER CURATIVE D2 GASTRECTOMY (ACTS-GC STUDY) (2010) (7)
Tumours of Oddi: Diagnosis and Surgical Treatment (1992) (7)
[Peritonitis following appendectomy]. (1985) (6)
Anatomical basis for clamping of the right hepatic vein outside the liver during right hepatectomy (2006) (6)
[Experimental models for hepatic metastases from colorectal tumors]. (1991) (6)
Immunogenicity of rat hepatocytes in vivo: effect of cholestasis-induced changes in major histocompatibility complex expression. (1993) (6)
Metabolism of beta-muricholic acid in man. (1985) (6)
[Hepatectomy with total vascular exclusion. Anatomical principles based on 64 dissections]. (1990) (6)
Surgical Strategies to Synchronous Colorectal Liver Metastases (2012) (6)
505PDPREOPERATIVE CHEMORADIOTHERAPY AND POSTOPERATIVE CHEMOTHERAPY WITH CAPECITABINE +/- OXALIPLATIN IN LOCALLY ADVANCED RECTAL CANCER: INTERIM ANALYSIS FOR DISEASE-FREE SURVIVAL OF PETACC 6. (2014) (6)
[Liver metastases from colorectal cancer: a multidisciplinary approach is necessary]. (2008) (5)
[Transplantation of isolated hepatocytes. State of current knowledges and perspectives]. (1994) (5)
Cytogenetic characterization of a colon adenocarcinoma from a familial polyposis coli patient. (1989) (5)
Interim analysis of a double-blind phase-III clinical trial of adjuvant levamisole versus control in resectable Dukes-C colon cancer: a study of the EORTC Gastrointestinal Tract Cancer Cooperative Group. (1988) (5)
Minimally-invasive approach for rectal cancer surgery. (2014) (4)
Reply to J.N. Primrose et al and C.-H. Köhne. (2015) (4)
The EORTC Gastrointestinal Tract Cancer Group: 50 years of research contributing to improved gastrointestinal cancer management (2012) (4)
[Recommendations for the management of gastro-intestinal stromal tumors]. (2006) (4)
[Intraperitoneal transplantation of isolated hepatocytes of the pig: the implantable bioartificial liver]. (1998) (4)
PETACC-6: Preop chemoradiation and postop chemotherapy (capecitabine +/- oxaliplatin) in locally advanced rectal cancer: Overall survival after long term follow-up. (2018) (4)
[Tolerance and efficacy of preoperative radiation therapy for elderly patients treated for rectal cancer]. (2013) (4)
Quantitation and modulation of hepatocyte major histocompatibility complex (MHC) expression: The effect of cholestasis and immunosuppressive drugs (1990) (4)
[Total pharyngolaryngoesophagectomy. Indications and results apropos of 17 cases]. (1992) (4)
Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG. European Organization for Research and Treatment of Cancer (1998) (4)
Total mesorectal excision for cancer: histological and immunohistochemical evidence of nerve removal and risk‐factor analysis (2016) (3)
An experimental model of colon cancer in the rat : effects of surgical trauma and immunosuppression on colonic carcinogenesis and spontaneous liver metastases (1991) (3)
[Established data and practical recommendations concerning pre- and postoperative chemotherapy of rectal cancer]. (1999) (3)
Can the left hepatic vein always be safely selectively clamped during hepatectomy? The contribution of anatomy. (2009) (3)
The role of irinotecan in the treatment of colorectal cancer metastases: surgeons and oncologists in partnership (2004) (3)
Transplantation of allogeneic isolated hepatocytes induces a specific prolongation of allograft survival. (1990) (3)
[Surgical resection of hepatocellular carcinoma. Retrospective study of 42 cases]. (1985) (3)
[Abdominal skin covering without traction. Principle of a new parietal treatment and applications to severe peritonitis and eventrations (sixty-six cases) (author's transl)]. (1981) (3)
[The mesorectum: an anatomical entity that is difficult to evaluate with MRI]. (2005) (3)
Single-layer anastomosis in surgery of the large bowel (1988) (3)
[Recent advances in the case management of colorectal cancer liver metastases]. (2003) (3)
[Colo-anal anastomosis with reservoir in the treatment of rectal cancer]. (1987) (3)
Surgical resection including peri-operative chemotherapy (adjuvant and neoadjuvant) (2003) (3)
Effect of Intraoperative Hypotension on Survival After Resection of Colorectal Liver Metastases (1992) (2)
Resection after chemotherapy (CT) with irinotecan (CPT) for initially unresectable liver metastasis (LM) from colorectal cancer (CRC) (2004) (2)
[The hazards of fixation of the small intestine and mesentery. Analysis of 52 complications and review of the literature]. (1983) (2)
[Postoperative peritonitis. Common data]. (1985) (2)
The European Organization for Research and Treatment of Cancer Gastrointestinal Group Trials: surgery and liver surgery in Europe. (2001) (2)
[Results of portal shunts for intractable ascites in patients with cirrhosis. 57 cases]. (1988) (2)
[Treatment of acute necrosis of the liver by hepatic transplantation. Comparative study of orthtopic and heterotopic grafts]. (1974) (2)
Surgery vs surgery and chemotherapy for colorectal liver metastases – Authors' reply (2008) (2)
Tyrosine metabolism in cirrhosis: acquired alkaptonuria. (1978) (2)
[Curative treatment of rectal cancer]. (1998) (2)
Repeat resections of primary hepatic malignancies. (1994) (2)
[Acute necroticohemorrhagic pancreatitis. Why, when and how to drain? Apropos of 106 cases]. (1989) (2)
How to manage splenic rupture during major liver resection? (2006) (2)
189. Local recurrence rates after RFA and resection of colorectal liver metastases – A descriptive analysis of EORTC CLOCC and EPOC databases (2012) (2)
[What can be done for patients with digestive cancer in 1999? Guidelines of the French Foundation of Digestive Cancerology (2nd part)]. (1999) (2)
gastrointestinal tumors 709 PD FIVE-YEAR RESULTS OF THE RANDOMIZED PHASE III TRIAL COMPARING S-1 MONOTHERAPY VERSUS SURGERY ALONE FOR STAGE II / III GASTRIC CANCER PATIENTS AFTER CURATIVE D 2 GASTRECTOMY ( ACTS-GC STUDY ) (2010) (2)
The Eortc Gastrointestinal Group Trials: Surgery and Liver Surgery in Europe (2001) (2)
H-Pouch: New Isoperistaltic Colonic Pouch For Coloanal Anastomosis After Rectal Resection For Cancer. A Pilot Study (2004) (2)
Predictive factors for the effect of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC phase III study 40983). (2010) (2)
[Idiopathic intestinal pseudo-obstruction. Apropos of a case treated with cholinergic and adrenolytic agents]. (1982) (1)
Sphincter-preserving surgery in patients with rectal cancer. (2000) (1)
Study of cyclosporin A blood level during the early post-liver-transplantation period. (1993) (1)
Severe Postoperative Peritonitis: Management with One-Stage Operation and Primary Closure of the Abdomen (1991) (1)
Prognostic factor of recurrence for resected digestive endocrine tumors. (2009) (1)
LIVER RESECTIONS FOR METASTATIC COLORECTAL CANCER (2003) (1)
Effect of reinfusion of ascitic fluid with the LeVeen shunt on fibrinogen and platelet survival. (1978) (1)
Progress in surgical oncology: a European perspective. Preface. (2008) (1)
Intraperitoneal or intraportal 5 FU combined with systemic chemotherapy for the adjuvant treatment of colorectal cancer: An EORTC (40911) and FFCD (9204) phase III study. (2004) (1)
Final results of the PETACC-1 trial of bolus 5-FU/LV vs raltitrexed: An unsuccessful story? (2008) (1)
Transplantation d'hépatocytes allogéniques sans immunosuppression: survie à long terme (1994) (1)
Surgery and chemotherapy combined for colorectal liver metastases. (2006) (1)
[Treatment of metastases of colorectal cancers]. (1994) (1)
Association of parathyroid adenoma and autonomous nodule of the thyroid. Diagnostic efficacy of 201thallium-99mtechnetium scintigraphy (2004) (1)
Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG. European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative Group. (1998) (1)
[Surgery of liver metastasis from colorectal cancer following irinotecan and 5FU-folinic acid]. (2004) (1)
Quality control (QC) tissue array for the prospective rvaluation of translational research projects. A program of the EORTC GI and RGB Groups (2005) (1)
[Surgical treatment of Oddi's sphincter tumors. Apropos of 56 cases]. (1988) (1)
Survival after peri-operative chemotherapy with folfox 4 and surgery for resectable colorectal cancer liver metastases. Final results of the eortc intergroup randomized phase III study 40983 (2007) (1)
[What can be done for digestive cancer in 1999? Recommendations of the French Foundation of Digestive Cancer (1st Part)]. (1999) (1)
Relationship between plasma and brain tryptophan in pigs during experimental hepatic coma before and after hemodialysis with selective membranes. (1981) (1)
[Transorificial intubation with direct neutralization of the digestive juices in cases of gastric or duodenal lesions. Principle and application of a new treatment for severe postoperative peritonitis of a gastric or duodenal origin (twenty-one cases) ]. (1982) (1)
[Treatment of liver metastases of colorectal cancers: how far should we go?]. (1998) (1)
The EORTC Gastrointestinal Tract Cancer Group: 40 years of research contributing to improved GI cancer management. (2002) (1)
[Selective distal spleno-renal shunt. A report of 14 patients (author's transl)]. (1979) (1)
Transplantation of allogeneic hepatocytes without immunosuppression: long-term survival. (1995) (1)
[Biliary scintigraphy. Application to the study of chronic cholestasis]. (1993) (1)
16th Round Table Symposium on Applied Immunology (1985) (1)
[Letter: Salmonella abscess of the spleen in a thalassemic patient]. (1974) (1)
Genomic profiling of ampullary adenocarcinoma (AA): Insights from a comparative analysis of pancreatic and intestinal adenocarcinoma and opportunities for targeted therapies use. (2017) (1)
New Neoadjuvant Chemotherapy for Resectable Liver Metastases of Colorectal Cancer (2017) (1)
[Cystadenoma of the pancreas. Which ones should be resected? 25 cases]. (1988) (1)
Resection after chemotherapy (CT) with irinotecan (CPT) for initially unresectable liver metastasis (LM) from colorectal cancer (CRC). (2004) (1)
[Congenital cysts and benign tumors of the liver in adults. What are the surgical indications? Apropos of 47 cases]. (1986) (1)
Adjuvant Therapy in Combination with Resection of Colorectal Cancer Metastasis to the Liver or Lungs (2014) (1)
[Palliative treatment of carcinoma of the hepatic duct junction. Intra-hepatic derivation or trans-tumoral intubation? (author's transl)]. (1982) (1)
Methods of surgical excision (1992) (1)
L'anastomose spléno-rénale distale (opération de Warren): 14 observations. (1979) (0)
[Benign teratoma of the thyroid in one adult]. (1988) (0)
Long term survival data from EORTC study 40983 : Perioperative chemotherapy for resectable liver metastases from colorectal cancer (2012) (0)
Invited commentary (2005) (0)
[May the treatment of adenomas of the colon and rectum still be surgical? (author's transl)]. (1981) (0)
[Cancer of the upper 3rd of the extra-hepatic bile ducts: surgical indication]. (1996) (0)
[Hepatocyte transplantation. Treatment of hepatic encephalopathy. An experimental study in the rat]. (1990) (0)
[Transplantation of allogeneic hepatocytes without immunosuppression: long-term survival]. (1994) (0)
Chairperson's Introduction (2007) (0)
[Bilio-biliary fistulas of lithiasic origin. Apropos of 8 cases]. (1986) (0)
[Postoperative peritonitis caused by lesion of the small intestine. Apropos of 217 cases]. (1985) (0)
P80 Can we limit postoperative delirium in patients older than 75 years after surgery for digestive cancer (2009) (0)
Practical therapeutic strategies (1992) (0)
Contents, Vol. 17, 1985 (1985) (0)
PG 8.2 Surgery versus radiofrequency ablation (Lessons from the CLOCC trial) (2014) (0)
Renal (Medical) (2006) (0)
Author Correction: Deep Learning and Radiomics predict complete response after neo-adjuvant chemoradiation for locally advanced rectal cancer (2018) (0)
[Tumors of the esophagus]. (2002) (0)
PG 8.1 Surgical strategies to synchronous rectal liver metastases: Chemotherapy before or after surgery or both (2014) (0)
Reply to letter: "Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983)". (2015) (0)
Subject Index Vol. 17, 1985 (1985) (0)
[The internal bioartifical liver]. (2001) (0)
[When is postoperative gastric suction useful? A randomized prospective study of 100 cases in biliary and colorectal surgery]. (1987) (0)
[Principles for the surgical treatment of severe liver injuries or why re-intervention is needed?]. (1991) (0)
[Ovarian adenocarcinoma, primary or metastasic tumour of an adenocarcinoma of the colon: the role of molecular biology]. (2004) (0)
Le pathologiste digital et le chirurgien (2019) (0)
[Functional outcome after hand-sewn versus stapled colonic J pouch anastomosis for rectal carcinoma]. (2009) (0)
Medical Management of the Surgical Patient. 4th Edn. M. F. Lubin, R. B. Smith III, T. F. Dodson, N. O. Spell and H. K. Walker (eds). 220 × 282 mm. Pp. 813. 2006. Cambridge University Press: Cambridge (2007) (0)
[63-year-old man who consulted for general altered state and rectal bleeding]. (2001) (0)
[News in the management of the hepatic metastases of colorectal cancer]. (2004) (0)
Intrasplenic transplantation of allogenic hepatocytes induces specific immune tolerance (1989) (0)
Subject Index Vol. 19, 1987 (1987) (0)
[Pleomorphic carcinoma of the large intestine]. (2003) (0)
[Toxic megacolon. Results of surgical treatment. Apropos of 70 cases]. (1988) (0)
[Current role of total esopharyngo-laryngectomy in cervico-facial cancerology. Apropos of 11 cases]. (1988) (0)
[Static tremor and encephalopathy disclosing Conn's syndrome]. (1989) (0)
[Reoperation in severe hepatic trauma. 30 cases]. (1990) (0)
[Left paraduodenal hernia and strangulation of the small intestine in a traumatic mesocolic tear]. (1975) (0)
28 Free Perforation (1999) (0)
Contents, Vol. 19, 1987 (1987) (0)
[Sensitivity of the liver to ischemia: a concept to reconsider]. (1979) (0)
Quality Assurance (2006) (0)
Tremblement d'attitude et encéphalopathie révélateurs d'un syndrome de Conn (1989) (0)
[Colorectal cancers: surgery of non-metastatic colonic and rectal cancer]. (2004) (0)
Experimental models of hepatic metastases of colorectal origin (1992) (0)
Surgical management of hepatic metastases from large bowel cancer. (1994) (0)
Management of Patients with Stage IV Colorectal Cancer (2012) (0)
Prof. Dr. med. Dr. med. h.c. Walter Brendel – 65 Years (1987) (0)
Subject Index Vol. 30, Suppl. 2, 2012 (2012) (0)
Deep Learning and Radiomics predict complete response after neo-adjuvant chemoradiation for locally advanced rectal cancer (2018) (0)
Adjuvant therapy for pancreatic cancer: current status and future directions (2004) (0)
194. Liver cancer (2012) (0)
Diagnosis and Treatment of Liver Metastases (2017) (0)
1056PDPROGNOSTIC IMPACT OF IMMUNE RESPONSE IN RESECTABLE COLORECTAL LIVER METASTASES TREATED WITH AND WITHOUT PERIOPERATIVE FOLFOX CHEMOTHERAPY. (2014) (0)
[The digital pathologist and the surgeon]. (2019) (0)
Adjuvant and neoadjuvant treatment in resectable and non-resectable metastatic colon cancer (2005) (0)
Health care delivery system in France: Effects on surgical education (1994) (0)
Oncosurge: A computer-based decision model to optimize therapeutic strategies in the management of patients with colorectal liver metastases (CLM) (2005) (0)
Liver and Biliary Tract Surgery: Embryological Anatomy to 3D-imaging and Transplant Innovations. C. Karaliotas, C. Broelsch and N. Habib (eds). 218 × 282 mm. Pp. 638. Illustrated. 2007. Springer: Vienna (2007) (0)
[Resection of liver metastasis of colo-rectal cancer]. (1989) (0)
[What role is left to surgery in portal hypertension?]. (1992) (0)
Colorectal cancer Reply (2010) (0)
Hepatic encephalopathy in portacaval shunted rats: intrasplenichepatocellular trans- plantation corrects striatal glutamine increase (1992) (0)
COMMENT JE TRAITE UNE CANCER DU COLON ET UN CANCER DU RECTUM (1994) (0)
Surgery and artificial intelligence: Just around the corner? (2021) (0)
Erratum to: Can the left hepatic vein always be safely selectively clamped during hepatectomy? The contribution of anatomy (2009) (0)
Multidisciplinary treatment of resectable liver metastases (including chemotherapy associated liver damage) (2007) (0)
Hope for cure - the concept of resection of CRC Liver metastases (2007) (0)
Neoadjuvant Chemotherapy Prior to Resection of Colorectal Liver Metastases (2012) (0)
[The Warren operation. Experiences with adults]. (1982) (0)
Can we use radiofrequency ablation for liver metastases from colorectal cancer over 25 mm initially but downsized by systemic chemotherapy (2015) (0)
European Society for Surgical Research: 29th Congress, Montpellier, May 1994; Abstracts (1994) (0)
[Surgical resection of hepatic metastases of colonic and rectal cancers. Apropos of 49 cases]. (1985) (0)
PG 8.3 Recurrence patterns after resection of liver metastases (2014) (0)
[Ulceration and stenosis of the small intestine after ingestion of potassium chloride tablets]. (1974) (0)
[Interest of a combined modality treatment in unresectable gallbladder carcinoma. A case report]. (2001) (0)
[Surgical resection of hepatic metastases of colorectal origin]. (1988) (0)
An international multidisciplinary approach to the management of advanced colorectal cancer (First of two parts) (Reprinted from Eur J Surg Oncol, vol 23, Suppl A, August 1997) (1998) (0)
[Thyroid cancer revealed by a suppressive hot nodule]. (1991) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Bernard M. Nordlinger?

Bernard M. Nordlinger is affiliated with the following schools: